Found 54 matching trials
Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers PHASE3 This is a randomized, multicenter, phase III trial comparing induction chem...
Show More Location
Hôpital de la Pitié-Salpétrière
Learn More & Join Trial
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) PHASE2 The primary objective of this study is to determine the response rate, tole...
Show More Location
Department of Radiation Oncology, Cancer Hospital, Fudan University
Learn More & Join Trial
Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC PHASE2 This is a prospective, open-label, multicenter, single-arm clinical study. ...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma N/A Two Phase Ⅲ trials (TAX323 and TAX324) showed induction chemotherapy adding...
Show More Location
Multiple Locations
Learn More & Join Trial
PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC PHASE2 More and more studies have shown that the efficacy and prognosis of HPV (Hu...
Show More Location
Eye & ENT Hospital of Fudan University
Learn More & Join Trial
Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma PHASE2 To determine the efficacy and safety of sequential chemoradiotherapy with r...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC PHASE3 This is a phase 3, multicentre, non-inferiority, randomised factorial trial...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) PHASE2 To evaluate the rate of clinical complete response 6-8 weeks after treatmen...
Show More Learn More & Join Trial
Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck PHASE3 This is a randomized multicenter open label phase III factorial trial evalu...
Show More Location
Istituto tumori "Giovanni Paolo II" IRCCS
Learn More & Join Trial
TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer PHASE2 A Phase II Trial With Radiotherapy Plus Cetuximab to Evaluate Specific Surv...
Show More Location
Hospital Germans Trias i Pujol
Learn More & Join Trial